A Study to Evaluate the Immune Response to the ASP7374 and Its Safety in Healthy Adult Volunteers

Update Il y a 4 ans
Reference: NCT01393951

Woman and Man

  • | Country :
  • Japan
  • | organs :
  • -
  • | Specialty :
  • -

Extract

This trial is designed as a blinded, randomized and parallel group study to investigate the clinically recommended dosage for ASP7374 based on the comparison of the immunogenicity and safety among two doses of subcutaneous ASP7374 and one dose of intramuscular ASP7374 in healthy adults.


Inclusion criteria

  • Healthy ,Immunogenicity of ASP7374

Links